 | ||
Acolbifene (INN) (developmental code names EM-652, SCH 57068) is a selective estrogen receptor modulator that, as of 2015, is in phase III clinical trials for the treatment of breast cancer.[1]
References
Acolbifene Wikipedia(Text) CC BY-SA
Acolbifene
Updated on
Edit
Like
Comment
Similar Topics